Orient Europharma Co Ltd Long-term Investment Intensity
Orient Europharma Co Ltd long-term investment intensity. Orient Europharma Co Ltd (4120) has a Long-term Investment Intensity of 1.9% as of December 2019. Long-term investments of NT$145.70 Million represent 1.9% of total assets of NT$7.87 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read 4120 total debt and obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Orient Europharma Co Ltd (2015–2019)
Long-term investment intensity of Orient Europharma Co Ltd from 2015 to 2019. This chart shows how Orient Europharma Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 1.9%, reflecting long-term investments of NT$145.70 Million against total assets of NT$7.87 Billion TWD.
Orient Europharma Co Ltd Long-term Investment Intensity by Year (2015–2019)
Orient Europharma Co Ltd long-term investment intensity by year from 2015 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Orient Europharma Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Orient Europharma Co Ltd.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.9% | NT$145.70 Million | NT$7.87 Billion | ▲ +0.4 pp |
| 2018 | 1.5% | NT$107.30 Million | NT$7.24 Billion | ▼ -1.4 pp |
| 2017 | 2.9% | NT$192.14 Million | NT$6.65 Billion | ▼ -1.1 pp |
| 2016 | 4.0% | NT$256.66 Million | NT$6.49 Billion | ▼ -0.6 pp |
| 2015 | 4.5% | NT$248.16 Million | NT$5.47 Billion | — |